Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: CPB for Arthroscopic Hip Surgery [NA]
A clinical trial registry entry evaluating CPB for pain management in arthroscopic hip surgery. The study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Life Care Specialists (LCS) With a Focus on Patient Pain Management and Prevention of Substance Misuse [NA]
Emory University conducted a trial evaluating Life Care Specialists for pain management and prevention of substance misuse in opioid use pat…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Pharmacokinetic Modeling of Methadone [NA]
A clinical trial evaluating pharmacokinetic modeling of methadone for opioid use disorder is currently recruiting at University Hospital, Mo…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Efficacy of Deep Transcranial Magnetic Stimulation in Patients With Opioid Use Disorder [NA]
This is a completed clinical trial evaluating the efficacy of deep transcranial magnetic stimulation for opioid use disorder. The document d…
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Focused Ultrasound for the Complex Patient [NA]
This clinical trial update indicates a focused ultrasound study for complex patients addressing opioid use disorder, chronic back pain, and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence. [Phase 4]
Phase 4 trial evaluating the safety of acute baclofen in methadone-maintained individuals with opioid use disorder; the study has completed …
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users. [Phase 1]
Phase 1 clinical trial assessing the effect of AZD4041 on respiratory drive in recreational opioid users has completed, with results posted.
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Role of High Frequency RTMS in Management of Opioid Use Disorder [NA]
This clinical trial update indicates that a study on high-frequency repetitive transcranial magnetic stimulation is enrolling by invitation …
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder [Phase 1, Phase 2]
This clinical trial update reports the completion and posting of results from a drug–drug interaction study testing lemborexant as an adjunc…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder [Phase 2]
This update reports that a Phase 2 trial evaluating emergency department-initiated treatment for adolescents with opioid use disorder has be…
-
CLINICAL_TRIALS research · 2024-11-12Clinical Trial Update: Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families [NA]
Phase II trial update on scalable digital delivery of CRAFT training for professionals to maximize treatment rates of opioid use disorder in…
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Pilot Study of Combined Treatment for Veterans With Chronic Pain & Opiate Misuse [NA]
This is a clinical trial update for a pilot study of a combined treatment approach for veterans with chronic pain and problematic opioid use…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Use of a GLP-1R Agonist to Treat Opioid Use Disorder [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trials evaluated a GLP-1 receptor agonist for opioid use disorder. The study is completed and results were posted o…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder [Phase 1]
Phase 1 study evaluating tezampanel for opioid withdrawal in treatment-seeking patients with opioid use disorder; recruitment is ongoing.
-
CLINICAL_TRIALS withdrawal · 2024-11-06Clinical Trial Update: Changing Opioid Users' Negative Attitudes Toward Medication Assisted Treatment [NA]
The clinical trial assessing attitudes toward medication-assisted treatment for opioid use disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density
This clinical trial update notes a completed study investigating chronic pain, opioid use, and epidermal nerve fiber density.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Examining an Adaptive Approach to Providing Psychosocial Support to Buprenorphine Patients [NA]
This clinical trial evaluating an adaptive psychosocial support approach for patients on buprenorphine for opioid use disorder has completed…
-
CLINICAL_TRIALS withdrawal · 2024-11-06Clinical Trial Update: A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder [Phase 2]
A Phase 2 trial evaluating ASP8062 as an add-on to buprenorphine/naloxone for opioid use disorder has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study
The MOM NEST trial evaluating the efficacy of naltrexone for maternal opioid use disorder and neonatal abstinence syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment [NA]
A completed Kaiser Permanente study evaluating the impact of screening for cannabis and other drug use disorders in primary care on subseque…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: CBT4CBT-Buprenorphine + Recovery Coach for Office-based Buprenorphine [NA]
A completed clinical trial evaluated CBT4CBT with buprenorphine and recovery coaching for office-based buprenorphine treatment in opioid use…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., granting approval for the gener…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Elite Laboratories, Inc.)
The FDA approved a supplemental application for methadone hydrochloride from Elite Laboratories, Inc., under an ANDA. This action updates th…
-
FDA approval · 2024-10-31FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc)
FDA approved Camber Pharmaceuticals' supplemental application for methadone hydrochloride, a generic product. This confirms regulatory clear…
-
FDA approval · 2024-10-31FDA Approved: BUPRENORPHINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for buprenorphine submitted by Teva Pharmaceuticals USA, Inc., indicating an approved update to …